ACTINIUM PHARMACEUTICALS INC's ticker is ATNM and the CUSIP is 00507W206. A total of 60 filers reported holding ACTINIUM PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is 0.70 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $205 | -28.3% | 21,650 | -19.4% | 0.02% | -42.1% |
| Q4 2022 | $286 | -99.7% | 26,854 | +113.3% | 0.04% | +322.2% |
| Q3 2022 | $93,000 | -45.9% | 12,590 | -64.8% | 0.01% | -40.0% |
| Q2 2022 | $172,000 | +138.9% | 35,789 | +154.0% | 0.02% | +200.0% |
| Q1 2022 | $72,000 | -14.3% | 14,090 | +0.5% | 0.01% | -44.4% |
| Q4 2021 | $84,000 | -60.9% | 14,020 | -49.1% | 0.01% | -60.9% |
| Q4 2020 | $215,000 | – | 27,524 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Corton Capital Inc. | 13,966 | $103,000 | 0.13% |
| Delphia (USA) Inc. | 14,226 | $105,000 | 0.12% |
| Sentinus, LLC | 22,500 | $166,000 | 0.10% |
| Intrepid Financial Planning Group LLC | 20,000 | $148,000 | 0.08% |
| PERRITT CAPITAL MANAGEMENT INC | 12,000 | $89,000 | 0.06% |
| J. Goldman & Co LP | 148,738 | $1,098,000 | 0.05% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 88,966 | $657,000 | 0.02% |
| EMFO, LLC | 1,666 | $12,000 | 0.01% |
| Virtu Financial LLC | 12,590 | $93,000 | 0.01% |
| Jump Financial, LLC | 23,400 | $173,000 | 0.01% |